Ellen A. Walker - Publications

Affiliations: 
Temple University, Philadelphia, PA, United States 
Area:
Behavioral Pharmacology Opioids, Serotonin

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ. Single and combined effects of delta(9) -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain. British Journal of Pharmacology. PMID 28548225 DOI: 10.1111/bph.13887  0.92
2016 Neelakantan H, Ward SJ, Walker EA. Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice. Experimental and Clinical Psychopharmacology. 24: 485-495. PMID 27929349 DOI: 10.1037/pha0000097  0.92
2015 Neelakantan H, Ward SJ, Walker EA. Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl/6 mice. Experimental and Clinical Psychopharmacology. 23: 217-27. PMID 26237319 DOI: 10.1037/pha0000028  0.92
2015 Ronca RD, Myers AM, Ganea D, Tuma RF, Walker EA, Ward SJ. A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice. Life Sciences. PMID 26032254 DOI: 10.1016/j.lfs.2015.05.005  1
2015 Neelakantan H, Tallarida RJ, Reichenbach ZW, Tuma RF, Ward SJ, Walker EA. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behavioural Pharmacology. 26: 304-14. PMID 25485642 DOI: 10.1097/FBP.0000000000000119  1
2015 Neelakantan H, Ward SJ, Walker EA. Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl/6 mice Experimental and Clinical Psychopharmacology. 23: 217-227. DOI: 10.1037/pha0000028  1
2014 Draghici B, Vullo D, Akocak S, Walker EA, Supuran CT, Ilies MA. Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect. Chemical Communications (Cambridge, England). 50: 5980-3. PMID 24763985 DOI: 10.1039/c4cc02346c  1
2014 Ward SJ, McAllister SD, Kawamura R, Murase R, Neelakantan H, Walker EA. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. British Journal of Pharmacology. 171: 636-45. PMID 24117398 DOI: 10.1111/bph.12439  1
2013 Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM, Rubin E, Pines A, Berkower EL, et al. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2427-38. PMID 23736314 DOI: 10.1038/npp.2013.143  1
2013 Bisen-Hersh EB, Hineline PN, Walker EA. Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3008-18. PMID 23596103 DOI: 10.1158/1078-0432.CCR-12-3764  1
2013 Krynetskiy E, Krynetskaia N, Rihawi D, Wieczerzak K, Ciummo V, Walker E. Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment. Life Sciences. 93: 605-10. PMID 23567806 DOI: 10.1016/j.lfs.2013.03.013  1
2013 Ganti V, Walker EA, Nagar S. Pharmacokinetic application of a bio-analytical LC-MS method developed for 5-fluorouracil and methotrexate in mouse plasma, brain and urine. Biomedical Chromatography : Bmc. 27: 994-1002. PMID 23494628 DOI: 10.1002/bmc.2893  1
2013 Walker EA. After chemo Scientist. 27.  1
2012 Neelakantan H, Walker EA. Temperature-dependent enhancement of the antinociceptive effects of opioids in combination with gabapentin in mice. European Journal of Pharmacology. 686: 55-9. PMID 22575516 DOI: 10.1016/j.ejphar.2012.04.042  1
2011 Ward SJ, Ramirez MD, Neelakantan H, Walker EA. Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice. Anesthesia and Analgesia. 113: 947-50. PMID 21737705 DOI: 10.1213/ANE.0b013e3182283486  1
2011 Bisen-Hersh EB, Hineline PN, Walker EA. Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models. Journal of Cancer. 2: 292-301. PMID 21611110  1
2011 Ward SJ, Rasmussen BA, Corley G, Henry C, Kim JK, Walker EA, Rawls SM. Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behavioural Pharmacology. 22: 370-3. PMID 21543969 DOI: 10.1097/FBP.0b013e3283473c10  1
2011 Walker EA, Foley JJ, Clark-Vetri R, Raffa RB. Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology. 217: 539-48. PMID 21537942 DOI: 10.1007/s00213-011-2310-8  1
2011 Bisen-Hersh EB, Hineline PN, Walker EA. Disruption of learning processes by chemotherapeutic agents in child-hood survivors of acute lymphoblastic leukemia and preclinical models Journal of Cancer. 2: 292-301. DOI: 10.7150/jca.2.292  1
2010 Walker EA. Animal models. Advances in Experimental Medicine and Biology. 678: 138-46. PMID 20738016 DOI: 10.1007/978-1-4419-6306-2_18  1
2010 Farrell M, Rosenzweig-Lipson S, Walker E. Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo. Psychopharmacology. 211: 149-59. PMID 20526585 DOI: 10.1007/s00213-010-1893-9  1
2010 Walker EA, Foley JJ. Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure. Behavioural Pharmacology. 21: 83-9. PMID 20177374 DOI: 10.1097/FBP.0b013e328337bde7  1
2009 Madia PA, Dighe SV, Sirohi S, Walker EA, Yoburn BC. Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse. Psychopharmacology. 207: 413-22. PMID 19816677 DOI: 10.1007/s00213-009-1673-6  1
2009 Ward SJ, Walker EA. Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice. Behavioural Pharmacology. 20: 605-13. PMID 19745722 DOI: 10.1097/FBP.0b013e328331ba30  1
2009 Ward SJ, Rosenberg M, Dykstra LA, Walker EA. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse. Drug and Alcohol Dependence. 105: 248-55. PMID 19679410 DOI: 10.1016/j.drugalcdep.2009.07.002  1
2009 Ward SJ, Lefever TW, Rawls SM, Whiteside GT, Walker EA. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. Psychopharmacology. 206: 155-65. PMID 19575185 DOI: 10.1007/s00213-009-1592-6  1
2008 Kumar P, Sunkaraneni S, Sirohi S, Dighe SV, Walker EA, Yoburn BC. Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation. European Journal of Pharmacology. 597: 39-45. PMID 18789923 DOI: 10.1016/j.ejphar.2008.08.025  1
2008 Sirohi S, Dighe SV, Walker EA, Yoburn BC. The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulation. Pharmacology, Biochemistry, and Behavior. 91: 115-20. PMID 18640146 DOI: 10.1016/j.pbb.2008.06.019  1
2008 Farrell MS, Gilmore K, Raffa RB, Walker EA. Behavioral characterization of serotonergic activation in the flatworm Planaria. Behavioural Pharmacology. 19: 177-82. PMID 18469535 DOI: 10.1097/FBP.0b013e3282fe885e  1
2008 Foley JJ, Raffa RB, Walker EA. Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology. 199: 527-38. PMID 18463849 DOI: 10.1007/s00213-008-1175-y  1
2008 Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA. Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. The Journal of Pharmacology and Experimental Therapeutics. 325: 567-76. PMID 18256173 DOI: 10.1124/jpet.107.131771  1
2007 Walker EA, Brown EK, Sterious SN. In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay. Psychopharmacology. 193: 187-97. PMID 17401722 DOI: 10.1007/s00213-007-0769-0  1
2007 Ward SJ, Walker EA, Dykstra LA. Effect of cannabinoid CB1 receptor antagonist SR141716A and CB1 receptor knockout on cue-induced reinstatement of Ensure and corn-oil seeking in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2592-600. PMID 17392737 DOI: 10.1038/sj.npp.1301384  1
2007 Pawar M, Kumar P, Sunkaraneni S, Sirohi S, Walker EA, Yoburn BC. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2. European Journal of Pharmacology. 563: 92-101. PMID 17349996 DOI: 10.1016/j.ejphar.2007.01.059  1
2006 Walker EA. In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay. British Journal of Pharmacology. 149: 1071-82. PMID 17075571 DOI: 10.1038/sj.bjp.0706946  1
2005 Walker EA, Kohut SJ, Hass RW, Brown EK, Prabandham A, Lefever T. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice. Neuropharmacology. 49: 1210-9. PMID 16165167 DOI: 10.1016/j.neuropharm.2005.07.015  1
2005 Comer SD, Sullivan MA, Walker EA. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. The Journal of Pharmacology and Experimental Therapeutics. 315: 1320-30. PMID 16144974 DOI: 10.1124/jpet.105.090423  1
2005 Comer SD, Walker EA, Collins ED. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers. Psychopharmacology. 181: 664-75. PMID 16025322 DOI: 10.1007/s00213-005-0023-6  1
2005 Walker EA, Sterious SN. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence. British Journal of Pharmacology. 145: 975-83. PMID 15912139 DOI: 10.1038/sj.bjp.0706247  1
2004 Raffa RB, Walker EA, Sterious SN. Opioid receptors and acetaminophen (paracetamol). European Journal of Pharmacology. 503: 209-10. PMID 15496316 DOI: 10.1016/j.ejphar.2004.08.055  1
2004 Walker EA, Picker MJ, Granger A, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. The Journal of Pharmacology and Experimental Therapeutics. 310: 150-8. PMID 15044559 DOI: 10.1124/jpet.103.058503  1
2003 Sterious SN, Walker EA. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. The Journal of Pharmacology and Experimental Therapeutics. 304: 301-9. PMID 12490605 DOI: 10.1124/jpet.102.042093  1
2002 Walker EA, Young AM. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine. The Journal of Pharmacology and Experimental Therapeutics. 302: 101-10. PMID 12065706 DOI: 10.1124/jpet.302.1.101  1
2001 Walker EA, Picker MJ, Dykstra LA. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids. Psychopharmacology. 155: 389-96. PMID 11441428 DOI: 10.1007/s002130100714  1
2001 Walker EA, Young AM. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology. 154: 131-42. PMID 11314675 DOI: 10.1007/s002130000620  1
2000 Zhang L, Walker EA, Sutherland J, Young AM. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology. 148: 136-45. PMID 10663428  1
1999 Walker EA, Hawkins ER, Tiano MJ, Picker MJ, Dykstra LA. Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons. Pharmacology, Biochemistry, and Behavior. 64: 445-8. PMID 10515328 DOI: 10.1016/S0091-3057(99)00086-6  1
1999 Walker EA, Tiano MJ, Benyas SI, Dykstra LA, Picker MJ. Naltrexone and beta-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d-propoxyphene. Psychopharmacology. 144: 45-53. PMID 10379623 DOI: 10.1007/s002130050975  1
1998 Pitts RC, Allen RM, Walker EA, Dykstra LA. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 285: 1197-206. PMID 9618423  1
1998 Walker EA, Zernig G, Young AM. In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay. Psychopharmacology. 136: 15-23. PMID 9537678 DOI: 10.1007/s002130050534  1
1997 Walker EA, Richardson TM, Young AM. Tolerance and cross-tolerance to morphine-like stimulus effects of mu opioids in rats. Psychopharmacology. 133: 17-28. PMID 9335076 DOI: 10.1007/s002130050366  1
1996 Walker EA, Richardson TM, Young AM. In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine. Psychopharmacology. 125: 113-9. PMID 8783384 DOI: 10.1007/BF02249409  1
1995 Walker EA, Zernig G, Woods JH. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. The Journal of Pharmacology and Experimental Therapeutics. 273: 1345-52. PMID 7791107  1
1994 Zernig G, Butelman ER, Lewis JW, Walker EA, Woods JH. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. The Journal of Pharmacology and Experimental Therapeutics. 269: 57-65. PMID 8169852  1
1994 Walker EA, Makhay MM, House JD, Young AM. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. The Journal of Pharmacology and Experimental Therapeutics. 271: 959-68. PMID 7965818  1
1993 Walker EA, Young AM. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. The Journal of Pharmacology and Experimental Therapeutics. 267: 322-30. PMID 8229759  1
1993 Walker EA, Butelman ER, DeCosta BR, Woods JH. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. The Journal of Pharmacology and Experimental Therapeutics. 267: 280-6. PMID 7901396  1
1992 Walker EA, Katon WJ, Jemelka RP, Roy-Bryne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. The American Journal of Medicine. 92: 26S-30S. PMID 1531168  0.01
1991 Walker EA, Yamamoto T, Hollingsworth PJ, Smith CB, Woods JH. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 259: 772-82. PMID 1941625  1
1991 Yamamoto T, Walker EA, Woods JH. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. The Journal of Pharmacology and Experimental Therapeutics. 258: 999-1007. PMID 1890629  1
1990 Walker EA, Woods JH. Apparent affinity estimates for nalbuphine, an opioid partial agonist, in a rhesus monkey tail-withdrawal procedure European Journal of Pharmacology. 183: 2304. DOI: 10.1016/0014-2999(90)93857-M  1
1990 Woods JH, France CP, Walker E, Bertalmio A, Winger GD. Narcotics European Journal of Pharmacology. 183: 37-38.  1
Show low-probability matches.